SCHEMBL9040004

SCHEMBL9040004

COC1(Cl)C=CC(/C=C/C(=O)c2ccccc2)C=C1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKT1 P31749 2/20 0.43
MAPT P10636 5/20 0.40
BCHE P06276 4/20 0.40
LMNA P02545 4/20 0.40
NPC1 O15118 3/20 0.40
RAB9A P51151 3/20 0.40
CYP3A4 P08684 2/20 0.40
NFKB1 P19838 2/20 0.40
NFKB2 Q00653 2/20 0.40
RELA Q04206 2/20 0.40
RECQL P46063 2/20 0.40
NPSR1 Q6W5P4 3/20 0.39
ALDH1A1 P00352 3/20 0.39
PLIN1 O60240 2/20 0.39
PLIN5 Q00G26 2/20 0.39
ABHD5 Q8WTS1 2/20 0.39
HPGD P15428 1/20 0.39
HTT P42858 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2C9 P11712 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8845815 0.84 RECQL (0.45) AKT1MAPTBCHELMNANPC1
SCHEMBL5928954 0.83 AKT1 (0.43) AKT1MAPTBCHELMNANPC1
SCHEMBL11826827 0.82 MAPT (0.42) AKT1MAPTBCHELMNANPC1
SCHEMBL7638894 0.82 GPR52 (0.40) AKT1MAPTBCHELMNANPC1
SCHEMBL10425119 0.79 MAPT (0.45) AKT1MAPTBCHELMNANPC1
SCHEMBL1470131 0.78 RECQL (0.50) AKT1MAPTBCHELMNANPC1
SCHEMBL9439994 0.78 MAPT (0.44) AKT1MAPTBCHELMNANPC1
SCHEMBL12484187 0.76 RECQL (0.40) AKT1MAPTBCHELMNANPC1
SCHEMBL6500192 0.76 RECQL (0.41) AKT1MAPTBCHELMNANPC1
SCHEMBL814596 0.74 RECQL (0.42) AKT1MAPTBCHELMNANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0731796-A1 1,3,5-TRISUBSTITUTED PYRAZOLE COMPOUNDS FOR TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-09-18 EP disclosed
WO-1995015318-A1 1,3,5-TRISUBSTITUTED PYRAZOLE COMPOUNDS FOR TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1995-06-08 WO disclosed